Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-15

Clinical Trial Update: Oxytocin Treatment of Alcohol Dependence [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oxytocin for alcohol dependence has been completed, and results have been posted. The sponsor is the University of North Carolina, Chap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxytocin (Oxytocin)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Alcohol Dependence | Phase 2 | Status: COMPLETED | Results posted: 2017-08-15